DAMORA THERAPEUTICS, INC. (DMRA) Free cash flow 2021–2022
DAMORA THERAPEUTICS, INC. (DMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$43.1MFY2022 · since FY2021: -$52.5M → -$43.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$43.1M | +17.9% |
| FY2021 | -$52.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice